Access a comprehensive collection of financial information about Aquestive. Download current and previous SEC filings, including earnings releases, and quarterly and annual reports.
Join upcoming meetings and listen to past sessions that review the Aquestive business landscape, including sales performance and objectives, product-development activities, and the status of strategic partnerships.
PharmFilm® technology and Aquestive's development expertise has created a robust, proprietary CNS and complex molecule portfolio. See the expanding collection of medicines designed to overcome barriers that the patients face.
In July 2018, the Company closed an IPO and began trading on the Nasdaq® Global Market under ticker symbol “AQST”.
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.